NVAX Novavax, Inc.
Healthcare$10.46+13.57%ClosedMarket Cap: $1.72B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$18.00
Target (Median)
$18.00
Target Range
$11.00 - $25.00
Upside from current price: 72.1%
Rating Distribution
0 Strong Buy5 Buy1 Hold1 Sell2 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | TD Cowen | maintain | Hold | Hold |
| 2026-02-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-20 | BTIG | maintain | Buy | Buy |
| 2025-11-18 | JP Morgan | maintain | Underweight | Underweight |
| 2025-11-10 | B. Riley Securities | maintain | Buy | Buy |
| 2025-11-04 | TD Cowen | maintain | Hold | Hold |
| 2025-10-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-20 | B of A Securities | downgrade | Underperform | Neutral |
| 2025-07-22 | B of A Securities | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.25 | $258.5M | 7 |
| Sun Dec 31 | $0.49 | $361.7M | 6 |
| Mon Dec 31 | $0.78 | $431.0M | 4 |
| Tue Dec 31 | $0.80 | $464.9M | 2 |